Potassium channels: Possible new therapeutic targets in Parkinson's disease

Medical Hypotheses

Volumn 71, Issue 4, 2008, Pages 546-550

  Wang, Yan ^a   Yang, Peng lin ^a   Tang, Ji fei ^a   Lin, Jia feng ^a   Cai, Xiao hong ^a   Wang, Xiao tong ^a   Zheng, Guo qing ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; POTASSIUM CHANNEL; SHAKER POTASSIUM CHANNEL;

ARTICLE; CELL LOSS; DOPAMINERGIC NERVE CELL; PARKINSON DISEASE; PATHOPHYSIOLOGY; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; HUMANS; MODELS, THEORETICAL; PARKINSON DISEASE; PILOT PROJECTS; POTASSIUM CHANNELS;

EID: 50449094196     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.05.021     Document Type: Article

References (25)

1. de Rijk M.C., Launer L.J., Berger K., Breteler M.M., Dartigues J.F., Baldereschi M., et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology 54 11 (2000) S21-S23
2. de Lau L., and Breteler M. Epidemiology of Parkinson's disease. Lancet Neurol 5 6 (2006) 525-535
3. Nussbaum R.L., and Ellis C.E. Alzheimer's disease and Parkinson's disease. N Engl J Med 348 14 (2003) 1356-1364
4. Singh N., Pillay V., and Choonara Y.E. Advances in the treatment of Parkinson's disease. Prog Neurobiol 81 1 (2007) 29-44
5. Lawson K., and McKay N.G. Modulation of potassium channels as a therapeutic approach. Curr Pharm Design 12 4 (2006) 459-470
6. Yost C.S. Potassium channels: basic aspects, functional roles, and medical significance. Anesthesiology 90 4 (1999) 1186-1203
7. Judge S.I., Smith P.J., Stewart P.E., and Bever Jr. C.T. Potassium channel blockers and openers as CNS neurologic therapeutic agents. Recent Pat CNS Drug Discov 2 3 (2007) 200-228
8. Clark A.G., Booth S.E., and Morrow J.A. Therapeutic potential of potassium channel modulators for CNS disorders. Expert Opin Ther Pat 13 1 (2003) 23-32
9. Chung Y.H., Shin C.M., Kim M.J., and Cha C.I. Immunohistochemical study on the distribution of six members of the Kv1 channel subunits in the rat basal ganglia. Brain Res 875 1-2 (2000) 164-170
10. Pal S., Hartnett K.A., Nerbonne J.M., Levitan E.S., and Aizenman E. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci 23 12 (2003) 4798-4802
11. Redman P.T., Jefferson B.S., Ziegler C.B., Mortensen O.V., Torres G.E., Levitan E.S., et al. A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity. Neuroscience 143 1 (2006) 1-6
12. Baranauskas G., Tkatch T., Nagata K., Yeh J.Z., and Surmeier D.J. Kv3.4 subunits enhance the repolarizing efficiency of Kv3.1 channels in fast-spiking neurons. Nat Neurosci 6 3 (2003) 258-266
13. ATP channels (review). Mol Membr Biol 18 2 (2001) 117-127
14. ATP channels, Kir61 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain. J Comp Neurol 484 3 (2005) 313-330
15. Zeng J., Wang G., and Chen S.D. ATP-sensitive potassium channels: novel potential roles in Parkinson's disease. Neurosci Bull 23 6 (2007) 370-376
16. ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 8 12 (2005) 1742-1751
17. Prüss H., Wenzel M., Eulitz D., Thomzig A., Karschin A., and Veh R.W. Kir2 potassium channels in rat striatum are strategically localized to control basal ganglia function. Brain Res Mol Brain Res 110 2 (2003) 203-219
18. Sailer C.A., Kaufmann W.A., Marksteiner J., and Knaus H.G. Comparative immunohistochemical distribution of three small-conductance Ca2+activated potassium channel subunits, SK1, SK2, and SK3 in mouse brain. Mol Cell Neurosci 26 3 (2004) 458-469
19. Wolfart J., and Roeper J. Selective coupling of t-type calcium channels to sk potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J Neurosci 22 9 (2002) 3404-3413
20. Ramanathan S., Tkatch T., Atherton J.F., Wilson C.J., and Bevan M.D. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels. J Neurophysiol 99 2 (2008) 442-459
21. Hervieu G.J., Cluderay J.E., Gray C.W., Green P.J., Ranson J.L., Randall A.D., and Meadows H.J. Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience 103 4 (2001) 899-919
22. Duprat F., Lesage F., Patel A.J., Fink M., Romey G., and Lazdunski M. The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK. Mol Pharmacol 57 5 (2000) 906-912
23. National Collaborating Centre for Chronic Conditions. Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care. London: Royal College of Physicians; 2006.
24. Deutch A.Y., and Winder D.G. A channel to neurodegeneration. Nat Med 12 1 (2006) 17-18
25. Chan C.S., Guzman J.N., Ilijic E., Mercer J.N., Rick C., Tkatch T., et al. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447 7148 (2007) 1081-1086